Filing Details
- Accession Number:
- 0001079973-12-000500
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-02 14:43:27
- Reporting Period:
- 2012-06-29
- Filing Date:
- 2012-07-02
- Accepted Time:
- 2012-07-02 14:43:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1167419 | Aspenbio Pharma Inc. | APPY | In Vitro & In Vivo Diagnostic Substances (2835) | 841553387 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408113 | Steve Lundy | C/O Aspenbio Pharma, Inc. 1585 S. Perry Street Castle Rock CO 80104 | President, Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-06-29 | 4,000 | $1.93 | 4,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
